We examined antioxidants exhibiting no effects on DNA cross-linking, which is the basis of psoralen and ultraviolet-A therapy for skin diseases, and suppressing oxidative DNA damage incidental to the therapy. Epigallocatechin gallate and esculetin effectively suppressed oxidative DNA damage with little effect on the formation of DNA cross-linking. These antioxidants might be useful in suppressing the adverse reaction induced by this therapy.
Photochemotherapy (PUVA) with psoralen derivatives, mainly 8-methoxypsoralen (8-MOP) and ultraviolet-A (UV-A, 320-400 nm) irradiation, is widely used in the treatment of skin diseases such as psoriasis and mycosis fungoides. 1) In PUVA therapy, psoralen derivatives cross-link with DNA by UV-A irradiation to inactivate the mitotic activity of target cells.
2) But PUVA also generates reactive oxygen species (ROS) during treatment.
3) ROS are responsible for oxidative stress to DNA, proteins, lipids, etc. in cells. PUVA is known to induce 8-oxo-2 0 -deoxyguanosine (8-oxodG), a biomarker of oxidative DNA damage, 4) in calf thymus DNA (ctDNA) and human epidermoid carcinoma cells. 5) Accumulation of oxidative DNA damage plays an important role in carcinogenesis. In fact, long-term PUVA therapy increases the risk of nonmelanoma skin cancer. 6) Finding antioxidants that inhibit oxidative DNA damage but not cross-linking is important for improving the safety of PUVA therapy, but there are no reports concerning such antioxidants. In this study, the effects of antioxidants on cross-linking and oxidative DNA damage by PUVA were examined using solutions of ctDNA.
We have examined the protective effects of different antioxidants against oxidative stress to cells caused by lipid peroxides. 7) In this study, we tested antioxidants such as epigallocatechin gallate (EGCG), a main antioxidant in green tea, L-ascorbic acid (AsA), esculetin, a natural coumarin compound distributed in a wide range of plants including chicory (Cichorium intybus) and dandelion (Taraxacum officinale), and 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid (trolox), a water-soluble vitamin E analog. Water for the hydrolysis of DNA was purified through a Millipore Milli Q system (Millipore, Bedford, MA) and then treated with Chelex 100 resin to remove trace amounts of transition metal ions such as iron ions. Solutions of ctDNA (200 mg), 8-MOP (0-300 mM), and antioxidants (0-750 mM) were added to the wells of a 96-well assay plate, and the final volume was adjusted to 100 ml with water. Mixtures were left for 30 min in the dark, and then exposed to 2.0 J/cm 2 of UV-A (320-380 nm) from UV irradiation equipment (HP-30BL; ATTO, Tokyo). After UV-A irradiation, aliquots (15 ml) of the mixtures were denatured by incubation in boiling water for 15 min followed by rapid cooling in ice-cold water for 15 min. Then the resulting solutions were diluted 100-fold with 0:5 Â TBE buffer consisting of 4.45 mM Tris, 4.45 mM boric acid, and 1 mM EDTA (pH 8.0). The diluted solutions (6 ml) were mixed with 0.3 M-sucrose (40 ml) and 0:5 Â TBE buffer (4 ml), and the mixtures (5 ml) were applied to a horizontal 2% agarose gel electrophoresis in 0:5 Â TBE buffer (100 V, 120 min). The agarose gel was stained with ethidium bromide (EtBr) and scanned with a fluorescent image analyzer (excitation wavelength, 532 nm; emission wavelength, 605 nm) (FMBIO II Multi View, Takara Bio, Shiga), and the ratio of cross-linked DNA was determined by comparison with the fluores- . Amounts of 8-oxodG in ctDNA treated by PUVA were detected by electrochemical detection as described previously. 8) Oxidative damage to DNA is expressed as the molar ratio of 8-oxodG to 10 5 dG. The amount of dG was calculated from absorption at 260 nm in the same sample. Data are expressed as mean AE SD. Scheffe's F-test was used for statistical analysis. Probability (p) values less than 0.05 were considered statistically significant.
Cross-linking of ctDNA by PUVA was dependent on the concentration of 8-MOP up to 200 mM with a plateau at higher concentrations (data not sown). From these results, 75 mM 8-MOP was used in experiments to study the effects of antioxidants. The contents of 8-oxodG increased significantly from 10:54 AE 0:61 to 21:10 AE 2:18 8-oxodG/10 5 dG by 2.0 J/cm 2 UV-A irradiation in the presence of 75 mM 8-MOP. The formation of 8-oxodG during PUVA was suppressed efficiently by treatment with 50 mM EGCG or esculetin (Fig. 1) . Trolox had no apparent effect on the formation of 8-oxodG up to 100 mM, but promoted 8-oxodG formation at 200 mM. AsA caused a dose-dependent exponential increase in the 8-oxodG level in DNA. DNA crosslinking was inhibited by all antioxidants used in this study, but their inhibitory abilities varied widely. Esculetin inhibited the formation of DNA cross-links by 8-MOP at 200 mM, while the inhibitory effects of EGCG were observed at 750 mM (Fig. 2) . At present, it is unclear why EGCG and esculetin show suppressive abilities against oxidative DNA damage, but trolox and AsA do not. The affinities for 8-MOP might be different among these antioxidants, since trolox and AsA are water-soluble and might be difficult to move closer to 8-MOP.
PUVA induces cross-linking with pyrimidine bases in DNA 9) and generates ROS such as superoxide or singlet oxygen. 10) Interstrand cross-linking of DNA with psoralen occurs by a type-I photosensitizing reaction, whereas oxidative DNA damage is formed by ROS induced from a type-II photosensitizing reaction. 10) Since cross-linked DNA remained undenatured, the single and double strand DNAs were separated by agarose-gel electrophoresis. The amount of DNA in agarose gels is estimated by measuring fluorescence intensity, 11) because this is in proportion to the amount of EtBr inserted into DNA. That is, the insertion of EtBr is proportional to the amount of double strand DNA. Based on the results of this study, PUVA treatment in the presence of EGCG or esculetin is expected to protect DNA against oxidative DNA damage and cross-linking of 8-MOP on DNA. These results suggest that some antioxidants can relieve the adverse effect, oxidative damage to cells, of PUVA therapy. Samples were treated similarly to the way described in the legend to Fig. 1 . Values represent the means AE SD of five separate experiments. *Significantly different at p < 0:01 vs. control DNA. **Significantly different at p < 0:05 vs. control DNA.
